Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning.

[1]  I. Kawase,et al.  STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart. , 2005, Cardiovascular research.

[2]  R. Bolli,et al.  IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. , 2004, Cardiovascular research.

[3]  M. Nitti,et al.  Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning. , 2004, Gastroenterology.

[4]  B. Pollwein,et al.  Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. , 2004, British journal of anaesthesia.

[5]  Lijun Tang,et al.  Protein kinase C-dependent activation of P44/42 mitogen-activated protein kinase and heat shock protein 70 in signal transduction during hepatocyte ischemic preconditioning. , 2004, World journal of gastroenterology.

[6]  P. Clavien,et al.  Ischemic preconditioning and intermittent clamping improve murine hepatic microcirculation and Kupffer cell function after ischemic injury , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  G. Farrell,et al.  Dual role of tumor necrosis factor‐α in hepatic ischemia‐reperfusion injury: Studies in tumor necrosis factor‐α gene knockout mice , 2004 .

[8]  H. Rüdiger,et al.  Sub-lethal oxidative stress triggers the protective effects of ischemic preconditioning in the mouse liver. , 2003, Journal of hepatology.

[9]  S. Akira,et al.  Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. , 2003, The Journal of clinical investigation.

[10]  H. Jaeschke,et al.  Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. , 2003, Gastroenterology.

[11]  U. Neumann,et al.  Clinical Implications of Hepatic Preservation Injury After Adult Liver Transplantation , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  R. Bolli,et al.  Mechanism of cyclooxygenase-2 upregulation in late preconditioning. , 2003, Journal of molecular and cellular cardiology.

[13]  I. Leclercq,et al.  Low‐dose TNF‐α protects against hepatic ischemia‐reperfusion injury in mice: Implications for preconditioning , 2003, Hepatology.

[14]  S. Fushida,et al.  Essential role for nuclear factor &kgr;B in ischemic preconditioning for ischemia-reperfusion injury of the mouse liver , 2002, Transplantation.

[15]  G. Farrell,et al.  Hepatic ischemic preconditioning in mice is associated with activation of NF‐κB, p38 kinase, and cell cycle entry , 2002, Hepatology.

[16]  J. Dufour,et al.  Extended preservation of rat liver graft by induction of heme oxygenase‐1 , 2002, Hepatology.

[17]  K. Olthoff.  Molecular Pathways of Regeneration and Repair after Liver Transplantation , 2002, World Journal of Surgery.

[18]  H. Rüdiger,et al.  Comparison of Ischemic Preconditioning and Intermittent and Continuous Inflow Occlusion in the Murine Liver , 2002, Annals of surgery.

[19]  K. Olthoff,et al.  Interleukin‐6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration , 2002, Hepatology.

[20]  R. Bartrons,et al.  Adenosine monophosphate–activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia‐reperfusion injury in the rat , 2001, Hepatology.

[21]  R. Bolli,et al.  An essential role of the JAK-STAT pathway in ischemic preconditioning , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Ciliberto,et al.  Interleukin-6 Protects against Fas-mediated Death by Establishing a Critical Level of Anti-apoptotic Hepatic Proteins FLIP, Bcl-2, and Bcl-xL* , 2001, The Journal of Biological Chemistry.

[23]  W. Meyers,et al.  Protein kinase C inhibition abrogates hepatic ischemic preconditioning responses. , 2001, The Journal of surgical research.

[24]  S. Rose-John,et al.  Hyper-IL-6 gene therapy reverses fulminant hepatic failure. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  P. Haddad,et al.  Role of hepatocytes and bile duct cells in preservation‐reperfusion injury of liver grafts , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  W. Meyers,et al.  Hemodynamic and metabolic variables predict porcine ex vivo liver function. , 2001, The Journal of surgical research.

[27]  J. Darnell,et al.  Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Farhood,et al.  Mechanism of cell death during warm hepatic ischemia‐reperfusion in rats: Apoptosis or necrosis? , 2001, Hepatology.

[29]  P. Schirmacher,et al.  Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration. , 2000, Gastroenterology.

[30]  J. Lemasters,et al.  Contribution of adenosine A2 receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers , 2000, Hepatology.

[31]  J. Devière,et al.  Cold liver ischemia‐reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice , 2000, Hepatology.

[32]  T. Hirano,et al.  Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors , 2000, Oncogene.

[33]  Roy Garcia,et al.  STATs in oncogenesis , 2000, Oncogene.

[34]  A. Billiau,et al.  Bimodal role of endogenous interleukin‐6 in concanavalin A‐induced hepatitis in mice , 2000, Journal of leukocyte biology.

[35]  E. Albano,et al.  Ischemic preconditioning reduces Na+ accumulation and cell killing in isolated rat hepatocytes exposed to hypoxia , 2000, Hepatology.

[36]  Gennaro Ciliberto,et al.  Increased toxin‐induced liver injury and fibrosis in interleukin‐6–deficient mice , 2000, Hepatology.

[37]  N. Maulik,et al.  Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. , 1999, Circulation.

[38]  A. Demetris,et al.  Mitosis and apoptosis in the liver of interleukin‐6–deficient mice after partial hepatectomy , 1999, Hepatology.

[39]  D. H. Mitchell,et al.  Regulation of CCAAT/Enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ischemia/reperfusion. , 1999, Circulation.

[40]  T. Hirano,et al.  Stat3 Is Required for the Gp130-mediated Full Activation of the C-myc Gene , 1999 .

[41]  T. Hirano,et al.  STAT3 orchestrates contradictory signals in cytokine‐induced G1 to S cell‐cycle transition , 1998, The EMBO journal.

[42]  P. Heinrich,et al.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. , 1998, The Biochemical journal.

[43]  P. Clavien,et al.  Interleukin‐6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent , 1997, Hepatology.

[44]  T. Hirano,et al.  Signaling mechanisms through gp130: a model of the cytokine system. , 1997, Cytokine & growth factor reviews.

[45]  J. Darnell.  STATs and gene regulation. , 1997, Science.

[46]  J. Engelhardt,et al.  CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. , 1997, The Journal of clinical investigation.

[47]  S. Bolling,et al.  Mediators of ischemia-reperfusion injury of rat lung. , 1997, The American journal of pathology.

[48]  P. Jolly,et al.  Morphological evidence of apoptosis and the prevalence of apoptotic versus mitotic cells in the membrana granulosa of ovarian follicles during spontaneous and induced atresia in ewes. , 1997, Biology of reproduction.

[49]  J. Peschon,et al.  Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  E. Furth,et al.  Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice , 1996, Science.

[51]  T. Shimabukuro,et al.  Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. , 1996, The Journal of laboratory and clinical medicine.

[52]  R. Rai,et al.  Review: Regulation of liver regeneration by pro‐inflammatory cytokines , 1996, Journal of gastroenterology and hepatology.

[53]  J. Ihle.  STATs: Signal Transducers and Activators of Transcription , 1996, Cell.

[54]  R. Taub,et al.  Rapid activation of the stat3 transcription complex in liver regeneration , 1995, Hepatology.

[55]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[56]  R. Zinkernagel,et al.  Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.

[57]  S. Akira,et al.  Cytokine signal transduction , 1994, Cell.

[58]  D. Shafritz,et al.  Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the D-galactosamine model of liver regeneration. , 1993, The American journal of pathology.

[59]  P. Chomczyński,et al.  A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. , 1993, BioTechniques.

[60]  L. Toledo-Pereyra,et al.  NEUTROPHIL INFILTRATION AS AN IMPORTANT FACTOR IN LIVER ISCHEMIA AND REPERFUSION INJURY , 1993, Transplantation.

[61]  M. Stegall,et al.  Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. , 1993, Transplantation.

[62]  R. Stratta,et al.  Diffuse biliary tract injury after orthotopic liver transplantation. , 1992, American journal of surgery.

[63]  T. Hirano.  The biology of interleukin-6. , 1992, Chemical immunology.

[64]  P. Clavien,et al.  Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. , 1992, Transplantation.

[65]  T. Hirano.  The Biology of Interleukin-6 (Part 1 of 2) , 1992 .

[66]  M. Dallman,et al.  Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. , 1991, Journal of immunology.

[67]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.

[68]  U. Mittmann,et al.  Postischemic liver damage in rats: effect of some therapeutic interventions on survival rate. , 1982, The Tohoku journal of experimental medicine.

[69]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[70]  S. Tschoeke,et al.  Splenic transposition is superior to caudal shunt as a model of murine total hepatic ischemia , 2005, Laboratory Investigation.

[71]  J. Gong,et al.  Protective effect of nitric oxide induced by ischemic preconditioning on reperfusion injury of rat liver graft. , 2004, World journal of gastroenterology.

[72]  Hartmut Jaeschke,et al.  Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[73]  T. Hirano.  Interleukin 6 and its receptor: ten years later. , 1998, International reviews of immunology.

[74]  G. Michalopoulos,et al.  Liver Regeneration , 1997, Science.

[75]  S. Akira,et al.  Biological and clinical aspects of interleukin 6. , 1990, Immunology today.

[76]  J. Cofer,et al.  The influence of preservation injury on rejection in the hepatic transplant recipient. , 1990, Transplantation.